Covered recipient · General Payments record
VICTORIA F RHODES
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$3,503.23
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,029.15 | 15 |
| Education | $106.67 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $316.01 | 4 |
| ABBVIE INC. | $156.16 | 4 |
| PFIZER INC. | $142.49 | 5 |
| Dermavant Sciences, Inc. | $131.47 | 1 |
| GlaxoSmithKline, LLC. | $125.00 | 1 |
| Paratek Pharmaceuticals, Inc. | $125.00 | 1 |
| Incyte Corporation | $121.39 | 1 |
| Phadia US Inc. | $18.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $124.99 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108080616 | CMS |
| ABBVIE INC. | $14.82 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108080618 | CMS |
| ABBVIE INC. | $7.90 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108080620 | CMS |
| ABBVIE INC. | $8.45 | 12/11/2024 | Education | Undisputed | 01/23/2026 | 1108080622 | CMS |
| Dermavant Sciences, Inc. | $131.47 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128007721 | CMS |
| GlaxoSmithKline, LLC. | $125.00 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116275683 | CMS |
| Incyte Corporation | $121.39 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141181700 | CMS |
| Janssen Biotech, Inc. | $115.75 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078278501 | CMS |
| Janssen Biotech, Inc. | $111.75 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078279089 | CMS |
| Janssen Biotech, Inc. | $82.95 | 04/23/2024 | Education | Undisputed | 01/23/2026 | 1078279405 | CMS |
| Janssen Biotech, Inc. | $5.56 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078279955 | CMS |
| Paratek Pharmaceuticals, Inc. | $125.00 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113933434 | CMS |
| PFIZER INC. | $18.63 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131808943 | CMS |
| PFIZER INC. | $78.97 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131826030 | CMS |
| PFIZER INC. | $18.91 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131821506 | CMS |
| PFIZER INC. | $15.27 | 07/11/2024 | Education | Undisputed | 01/23/2026 | 1131801951 | CMS |
| PFIZER INC. | $10.71 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131893030 | CMS |
| Phadia US Inc. | $18.30 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067587752 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.